Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2019 | 75 | 08 |
Tytuł artykułu

Parwowiroza psów - problem wciąż aktualny

Warianty tytułu
Canine parvovirosis: Still an existing problem
Języki publikacji
Parvoviral infections of dogs are still a clinical problem throughout the world. This is despite the development of prevention, increased awareness among the owners and increasingly effective treatment protocols due to the extremely high virulence of the virus. Parvovirosis is a disease caused by a virus of the Parvoviridae family in various variants: CPV-2, CPV-2a, CPV-2b and CPV-2c, all of which produce similar clinical signs, including acute hemorrhagic enteritis and myocarditis. It is one of the most important viral pathogens, with extremely high morbidity and mortality. This study is a compendium of current knowledge about parvoviral infections in dogs. It describes their aetiology, pathogenesis and factors predisposing to parvovirosis. Special emphasis is placed on the description of clinical signs and treatment of sick dogs. Various diagnostic methods that are necessary to make the final diagnosis of the disease are described. The recommendations of the WSAVA on prophylactic vaccination are also analyzed.
Opis fizyczny
  • Katedra Epizootiologii i Klinika Chorób Zakaźnych, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul.Głęboka 30, 20-612 Lublin
  • Katedra Epizootiologii i Klinika Chorób Zakaźnych, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul.Głęboka 30, 20-612 Lublin
  • Katedra Epizootiologii i Klinika Chorób Zakaźnych, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul.Głęboka 30, 20-612 Lublin
  • Agungpriyono D. R., Uchida K., Tabaru H., Yamaguchi R., Tateyama S.: Subacute massive necrotizing myocarditis by canine parvovirus type 2 infection with diffuse leukoencephalomalacia in a puppy. Vet. Pathol. 1999, 36, 77-80.
  • Albaz A. Z., Sayed-Ahmed M., Younis E., Khodier M.: Investigation of the Antiviral effect of Acyclovir on Canine Parvovirus Infection. Pharm. Pharmacol. Int. J. 2015, 2, 36-39.
  • Bastan I., Kurtdede A., Özen D.: Prognostic usefulness of some parameters in dogs with canine parvovirus. Ank. Üniversitesi. Vet. Fakültesi. Derg. 2013, 60, 53-58.
  • Benchaoui H. A., Cox S. R., Schneider R. P., Boucher J. F., Clemence R. G.: The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs. J. Vet. Pharmacol. Ther. 2007, 30, 336-344.
  • Bird L., Tappin S.: Canine parvovirus: where are we in the 21st Century? Companion Anim. 2013, 18, 142-146.
  • Bragg R. F., Duffy A. L., DeCecco F. A., Chung D. K., Green M. T., Veir J. K., Dow S. W.: Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection. J. Am. Vet. Med. Assoc. 2012, 240, 700-704.
  • Buonavoglia C., Martella V., Pratelli A., Tempesta M., Cavalli A., Buonavoglia D., Bozzo G., Elia G., Decaro N., Carmichael L.: Evidence for evolution of canine parvovirus type 2 in Italy. J. Gen. Virol. 2001, 82, 3021-3025.
  • Castro T. X., Miranda S. C., Labarthe N. V., Silva L. E., Cubel Garcia R. C. N.: Clinical and epidemiological aspects of canine parvovirus (CPV) enteritis in the State of Rio de Janeiro: 1995-2004. Arq. Bras. Med. Veterinária E Zootec. 2007, 59, 333-339.
  • Cavalli A., Bozzo G., Decaro N., Tinelli A., Aliberti A., Buonavoglia D.: Characterization of a canine parvovirus strain isolated from an adult dog. New Microbiol. 2001, 24, 239-242.
  • Cotmore S. F., Agbandje-McKenna M., Chiorini J. A., Mukha D. V., Pintel D. J., Qiu J., Soderlund-Venermo M., Tattersall P., Tijssen P., Gatherer D., Davison A. J.: The family Parvoviridae. Arch. Virol. 2014, 159, 1239-1247.
  • Day M. J., Horzinek M., Schulz R., Squires R.: WSAVA guidelines for the vaccination of the dogs and cats. J. Small. Anim. Pr. 2016, 51, 1-45.
  • Decaro N., Campolo M., Desario C., Elia G., Martella V., Lorusso E., Buonavoglia C.: Maternally-derived antibodies in pups and protection from canine parvovirus infection. Biol. J. Int. Assoc. Biol. Stand. 2005, 33, 261-267.
  • Decaro N., Martella V., Elia G., Desario C., Campolo M., Lorusso E., Colaianni M. L., Lorusso A., Bounavoglia C.: Tissue distribution of the antigenic variants of canine parvovirus type 2 in dogs. Vet. Microbiol. 2007, 121, 39-44.
  • Desario C., Decaro N., Campolo M., Cavalli A., Cirone F., Elia G., Martella V., Lorusso E., Camero M., Buonavoglia C.: Canine parvovirus infection: which diagnostic test for virus? J. Virol. Methods 2005, 126, 179-185.
  • Elia G., Cavalli A., Desario C., Lorusso E., Lucente M. S., Decaro N., Martella V., Buonavoglia C.: Detection of infectious canine parvovirus type 2 by mRNA real-time RT-PCR. J. Virol. Methods 2007, 146, 202-208.
  • Elwood C., Devauchelle P., Elliott J., Freiche V., German A. J., Gualtieri M., Hall E., den Hertog E., Neiger R., Peeters D., Roura X., Savary-Bataille K.: Emesis in dogs: a review. J. Small Anim. Pract. 2010, 51, 4-22.
  • Esfandiari J., Klingeborn B.: A comparative study of a new rapid and one-step test for the detection of parvovirus in faeces from dogs, cats and mink. J. Vet. Med. B. Infect. Dis. Vet. Public Health 2000, 47, 145-153.
  • Freisl M., Speck S., Truyen U., Reese S., Proksch A.-L., Hartmann K.: Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs. Vet. J. 2017, 219, 15-21.
  • Gerlach M., Proksch A. L., Unterer S., Speck S., Truyen U., Hartmann K.: Efficacy of feline anti-parvovirus antibodies in the treatment of canine parvovirus infection. J. Small Anim. Pract. 2017, 58, 408-415.
  • Goddard A., Leisewitz A. L., Christopher M. M., Duncan N. M., Becker P. J.: Prognostic Usefulness of Blood Leukocyte Changes in Canine Parvoviral Enteritis. J. Vet. Intern. Med. 2008, 22, 309-316.
  • Houston D. M., Ribble C. S., Head L. L.: Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982-1991). J. Am. Vet. Med. Assoc. 1996, 208, 542-546.
  • Kalli I., Leontides L. S., Mylonakis M. E., Adamama-Moraitou K., Rallis T., Koutinas A. F.: Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection. Res. Vet. Sci. 2010, 89, 174-178.
  • Kalli I. V., Adamama-Moraitou K. K., Patsika M. N., Pardali D., Steiner J. M., Suchodolski J. S., Menexes G., Brellou G. D., Rallis T. S.: Prevalence of increased canine pancreas-specific lipase concentrations in young dogs with parvovirus enteritis. Vet. Clin. Pathol. 2017, 46, 111-119.
  • Khatri R., Poonam Mohan H., Minakshi Pundir C. S.: Epidemiology, Pathogenesis, Diagnosis and Treatment of Canine Parvovirus Disease in Dogs: A Mini Review. J. Vet. Sci. Med. Diagn. 2017, 6, 3.
  • Kim Y. K., Lim S. I., Choi S., Cho I. S., Park E. H., An D. J.: A novel assay for detecting canine parvovirus using a quartz crystal microbalance biosensor. J. Virol. Methods 2015, 219, 23-27.
  • Kraft W., Kuffer M.: Treatment of severe neutropenias in dogs and cats with filgrastim. Tierarztl Prax. 1995, 23, 609-613.
  • Kuwabara M., Nariai Y., Horiuchi Y., Nakajima Y., Yamaguchi Y., Horioka E., Kawanabe M., Kubo T., Yukawa M., Sakai T.: Immunological effects of recombinant feline interferon-omega (KT-80) administration in the dog. Microbiol. Immunol. 2006, 50, 637-641.
  • Lamm C. G., Rezabek G. B.: Parvovirus infection in domestic companion animals. Vet. Clin. North Am. Small Anim. Pract. 2008, 38, 837-850.
  • Larson L. J., Schultz R. D.: Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant? Vet. Ther. Res. Appl. Vet. Med. 2008, 9, 94-101.
  • Lobetti R. G., Joubert K. E., Picard J., Carstens J., Pretorius E.: Bacterial colonization of intravenous catheters in young dogs suspected to have parvoviral enteritis. J. Am. Vet. Med. Assoc. 2002, 220, 1321-1324.
  • Lothrop C. D., Warren D. J., Souza L. M., Jones J. B., Moore M. A.: Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor. Blood 1988, 72, 1324-1328.
  • MaCartney L., MaCartney C. M.: Canine parvovirus: development of immunofluorescence and immunoperoxidase techniques. Res. Vet. Sci. 1986, 40, 201-208.
  • Mari K. de, Maynard L., Eun H. M., Lebreux B.: Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial. Vet. Rec. 2003, 152, 105-108.
  • Martin V., Najbar W., Gueguen S., Grousson D., Eun H. M., Lebreux B., Aubert A.: Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet. Microbiol. 2002, 89, 115-127.
  • McClure V., van Schoor M., Thompson P. N., Kjelgaard-Hansen M., Goddard A.: Evaluation of the use of serum C-reactive protein concentration to predict outcome in puppies infected with canine parvovirus. J. Am. Vet. Med. Assoc. 2013, 243, 361-366.
  • Meunier P. C., Glickman L. T., Appel M. J., Shin S. J.: Canine parvovirus in a commercial kennel: epidemiologic and pathologic findings. Cornell Vet. 1981, 71, 96-110.
  • Minagawa T., Ishiwata K., Kajimoto T.: Feline interferon-omega treatment on canine parvovirus infection. Vet. Microbiol. 1999, 69, 51-53.
  • Minakshi P., Basanti B., Sunderisen K., Jiju V. T., Savi J., Ikbal, Koushlesh R., Upendera L., Madhusudan G., Nitish B., Pawan K., Vinay G. J., Rahul K., Hari M., Pundir C. S., Sandip K. K., Prasad G.: Canine parvovirus – an insight into diagnostic aspect. J. Exp. Biol. Agric. Sci. 2016, 4, 279-290.
  • Mischke R., Barth T., Wohlsein P., Rohn K., Nolte I.: Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis. Res. Vet. Sci. 2001, 70, 221-225.
  • Mylonakis M. E., Kalli I., Rallis T. S.: Canine parvoviral enteritis: an update on the clinical diagnosis, treatment, and prevention. Vet. Med.: Research and Reports 2016, 7, 91-100.
  • Nandi S., Kumar M., Mahapatra T. K., Ravishankar C.: Emergence of Canine Parvovirus – 2 variants and its impact on vaccination. World Appl. Sci. J. 2013, 23, 1366-1376.
  • Nappert G., Dunphy E., Ruben D., Mann F. A.: Determination of serum organic acids in puppies with naturally acquired parvoviral enteritis. Can. J. Vet. Res. 2002, 66, 15-18.
  • Niyom S., Boscan P., Twedt D. C., Monnet E., Eickhoff J. C.: Effect of maropitant, a neurokinin-1 receptor antagonist, on the minimum alveolar concentration of sevoflurane during stimulation of the ovarian ligament in cats. Vet. Anaesth. Analg. 2013, 40, 425-431.
  • O’Sullivan G., Durham P. J., Smith J. R., Campbell R. S.: Experimentally induced severe canine parvoviral enteritis. Aust. Vet. J. 1984, 61, 1-4.
  • Otto C. M., Jackson C. B., Rogell E. J., Prior R. B., Ammons W. S.: Recombinant bactericidal/permeability-increasing protein (rBPI21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial. J. Vet. Intern. Med. 2001, 15, 355-360.
  • Otto C. M., Rieser T. M., Brooks M. B., Russell M. W.: Evidence of hypercoagulability in dogs with parvoviral enteritis. J. Am. Vet. Med. Assoc. 2000, 217, 1500-1504.
  • Panda D., Patra R. C., Nandi S., Swarup D.: Oxidative stress indices in gastroenteritis in dogs with canine parvoviral infection. Res. Vet. Sci. 2009, 86, 36-42.
  • Pollock R. V.: Experimental canine parvovirus infection in dogs. Cornell Vet. 1982, 72, 103-119.
  • Pospischil A., Yamaho H.: Parvovirus enteritis in dogs based on autopsy statistics 1978-1985. Tierarztl Prax. 1987, 15, 67-71.
  • Prittie J.: Canine parvoviral enteritis: a review of diagnosis, management, and prevention. J. Vet. Emerg. Crit. Care 2004, 14, 167-176.
  • Priya A. K., Balagangatharathilagar M., Chandrasekaran D., Parthiban M., Prathaban S.: Prevalence of enteropathogens and their antibiotic sensitivity pattern in puppies with hemorrhagic gastroenteritis. Vet. World 2017, 10, 859-863.
  • Proksch A. L., Unterer S., Speck S., Truyen U., Hartmann K.: Influence of clinical and laboratory variables on faecal antigen ELISA results in dogs with canine parvovirus infection. Vet. J. 2015, 204, 304-308.
  • Rallis T. S., Papazoglou L. G., Adamama-Moraitou K. K., Prassinos N. N.: Acute enteritis or gastroenteritis in young dogs as a predisposing factor for intestinal intussusception: a retrospective study. J. Vet. Med. A. Physiol. Pathol. Clin. Med. 2000, 47, 507-511.
  • Ramsey D. S., Kincaid K., Watkins J. A., Boucher J. F., Conder G. A., Eagleson J. S., Clemence R. G.: Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs. J. Vet. Pharmacol. Ther. 2008, 31, 538-543.
  • Reddy K. B., Shobhamani B., Sreedevi B., Prameela D. R., Reddy B. S.: Canine parvo viral infection in dogs and their treatment. Int. J. Vet. Sci. 2015, 4, 142-144.
  • Riedl M., Truyen U., Reese S., Hartmann K.: Prevalence of antibodies to canine parvovirus and reaction to vaccination in client-owned, healthy dogs. Vet. Rec. 2015, 177, 597.
  • Robinson W. F., Huxtable C. R., Pass D. A.: Canine parvoviral myocarditis: a morphologic description of the natural disease. Vet. Pathol. 1980, 17, 282-293.
  • Sanekata T., Sugimoto T., Ueda S., Tsubokura M., Yamane Y., Senda M.: Latex agglutination test for canine parvovirus. Aust. Vet. J. 1996, 73, 215-217.
  • Savigny M. R., Macintire D. K.: Use of oseltamivir in the treatment of canine parvoviral enteritis. J. Vet. Emerg. Crit. Care. San Antonio Tex. 2010, 20, 132-142.
  • Schoeman J. P., Goddard A., Herrtage M. E.: Serum cortisol and thyroxine concentrations as predictors of death in critically ill puppies with parvoviral diarrhea. J. Am. Vet. Med. Assoc. 2007, 231, 1534-1539.
  • Sharma P., Rastogi A., Kukreti K., Narwal P. S.: Sensitivity assay of polymerase chain reaction for detection of Canine Parvo Virus infection in dogs. OJCD 2012, 2, 45-47.
  • Stander N., Wagner W. M., Goddard A., Kirberger R. M.: Ultrasonographic appearance of canine parvoviral enteritis in puppies. Vet. Radiol. Ultrasound Off. J. Am. Coll. Vet. Radiol. Int. Vet. Radiol. Assoc. 2010, 51, 69-74.
  • Studdert M. J., Oda C., Riegl C. A., Roston R. P.: Aspects of the diagnosis, pathogenesis and epidemiology of canine parvovirus. Aust. Vet. J. 1983, 60, 197-200.
  • Sykes J. E.: Canine Parvovirus Infections and Other Viral Enteritides. Canine Feline Infect. Dis. 2013, 141-151.
  • Venn E. C., Preisner K., Boscan P. L., Twedt D. C., Sullivan L. A.: Evaluation of an outpatient protocol in the treatment of canine parvoviral enteritis. J. Vet. Emerg. Crit. Care 2017, 27, 52-65.
  • Vojtek B., Mojžišová J., Smrčo P., Drážovská M.: Effects of orally administered β-1,3/1,6-glucan on vaccination responses and immunological parameters in dogs. Food Agric. Immunol. 2017, 28, 993-1002.
  • Wang X., Ren L., Tu Q., Wang J., Zhang Y., Li M., Liu R., Wang J.: Magnetic protein microbead-aided indirect fluoroimmunoassay for the determination of canine virus specific antibodies. Biosens. Bioelectron. 2011, 26, 3353-3560.
  • Yalcin E., Keser G. O.: Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs. J. Vet. Pharmacol. Ther. 2017, 40, 599-603.
  • Yilmaz Z., Senturk S.: Characterisation of lipid profiles in dogs with parvoviral enteritis. J. Small Anim. Pract. 2007, 48, 643-650.
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.